CBD Shows Promise for Anxiety and Sleep, But Evidence Quality Varies Widely | Research

The takeaway

A scoping review of 29 studies found that cannabinoids, particularly CBD, showed potential for improving both anxiety and sleep disturbances, but major differences in study design and dosing limit conclusions.

People with anxiety-related sleep problems, clinicians considering cannabinoid prescriptions, researchers designing cannabis clinical trials

45% of studies reported positive effects on both anxiety and sleep

What the researchers found

Of 29 studies meeting inclusion criteria, about 45% reported positive effects on both anxiety and sleep outcomes. CBD was the most commonly studied cannabinoid with the most consistent positive results. However, substantial heterogeneity in study design, cannabinoid types, dosing regimens, and outcome measures limited the ability to draw definitive conclusions or establish standardized dosing.

Why it matters

At least 60% of people with anxiety disorders also have sleep problems, and both conditions share physiological mechanisms. CBD's potential to address both simultaneously would be clinically valuable, but this review shows the evidence base needs more rigorous, standardized research to support clinical recommendations.

The numbers in context

1,132 documents retrieved, 29 met inclusion criteria. ~45% reported positive effects on both anxiety and sleep. Scientific literature on medical cannabis for these conditions increased approximately 15-fold in the last decade. CBD was the cannabinoid with the most consistent evidence.

How the study worked

Scoping review searching PubMed, EMBASE, Cochrane, CINAHL, LILACS, and PsycINFO. From 1,132 retrieved documents, 29 met inclusion criteria, including RCTs, observational studies, and case series. Quality assessment was conducted for each study.

What this study cannot tell us

Scoping review has inherent limitations compared to systematic reviews with meta-analysis. Heterogeneous study designs prevent quantitative pooling of results. Many included studies were small or observational. Positive publication bias may inflate the apparent efficacy.

How to read the evidence

Moderate evidence strength for the field overall based on 29 studies, though heterogeneity limits the strength of any individual conclusion.

When this study was published

2025 scoping review covering the current state of cannabinoid research for anxiety and sleep.

The bigger picture

The rapid growth in cannabis research (15-fold in a decade) reflects both public interest and scientific recognition of cannabinoids' therapeutic potential. However, the field has been hampered by inconsistent methodologies, making it difficult to translate promising findings into clinical practice. Standardized dosing protocols and outcome measures are urgently needed.

Questions still open

What is the optimal CBD dose for combined anxiety-sleep benefits? How do different cannabinoid formulations compare in efficacy? Would standardized outcome measures in future studies allow for meaningful meta-analysis?

Common questions

Does CBD help with anxiety and sleep?

About 45% of the 29 studies reviewed reported positive effects on both anxiety and sleep. CBD was the cannabinoid with the most consistent evidence. However, differences in dosing, formulations, and study designs mean there is not yet enough evidence to establish standardized treatment protocols.

Why isn't there a clear answer yet?

The research field has grown rapidly but lacks consistency. Studies use different cannabinoid types, doses, and ways of measuring outcomes. Future research needs standardized methods, including dose-response studies, to provide the clear evidence needed for clinical guidelines.

Read the original research

Cannabinoids for Anxiety and Sleep Disturbances: A Scoping Review.

Medical cannabis and cannabinoids, 8(1), 219-237

View on PubMed ↗Publisher’s paper ↗

Citation

Perez, Juan G; LaMontagne, Liva G; Garcia, Gabriela A; Vaddiparti, Krishna; Gupta, Pranav S; Churba, Benjamin Z; Hossain, Ryan; Lopez-Quintero, Catalina. (2025). Cannabinoids for Anxiety and Sleep Disturbances: A Scoping Review.. Medical cannabis and cannabinoids, 8(1), 219-237. https://doi.org/10.1159/000548890